Cheviot Value Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.41M Buy
3,892
+130
+3% +$44.5K 0.14% 57
2026
Q1
$1.32M Hold
3,762
0.13% 56
2025
Q4
$1.29M Hold
3,762
0.13% 57
2025
Q3
$1.1M Hold
3,762
0.12% 59
2025
Q2
$1.08M Hold
3,762
0.12% 56
2025
Q1
$1.05M Buy
3,762
+4
+0.1% +$1.18K 0.13% 53
2024
Q4
$979K Hold
3,758
0.19% 42
2024
Q3
$1.21M Sell
3,758
-4
-0.1% -$1.31K 0.23% 40
2024
Q2
$1.18M Buy
3,762
+15
+0.4% +$4.41K 0.23% 40
2024
Q1
$1.07M Hold
3,747
0.23% 34
2023
Q4
$1.08M Sell
3,747
-250
-6% -$68.1K 0.23% 39
2023
Q3
$1.07M Hold
3,997
0.24% 38
2023
Q2
$887K Buy
3,997
+12
+0.3% +$2.78K 0.19% 39
2023
Q1
$963K Buy
3,985
+293
+8% +$71.9K 0.23% 38
2022
Q4
$970K Hold
3,692
0.24% 38
2022
Q3
$832K Hold
3,692
0.23% 38
2022
Q2
$898K Hold
3,692
0.22% 41
2022
Q1
$893K Buy
3,692
+1,705
+86% +$392K 0.19% 43
2021
Q4
$447K Hold
1,987
0.1% 51
2021
Q3
$423K Sell
1,987
-4
-0.2% -$921 0.11% 51
2021
Q2
$485K Hold
1,991
0.12% 53
2021
Q1
$495K Buy
1,991
+80
+4% +$19.1K 0.14% 51
2020
Q4
$439K Buy
1,911
+280
+17% +$64.6K 0.13% 49
2020
Q3
$415K Sell
1,631
-47
-3% -$11.6K 0.14% 42
2020
Q2
$396K Sell
1,678
-3
-0.2% -$684 0.15% 43
2020
Q1
$341K Sell
1,681
-103
-6% -$22.5K 0.16% 47
2019
Q4
$430K Sell
1,784
-40
-2% -$8.82K 0.17% 55
2019
Q3
$353K Hold
1,824
0.15% 55
2019
Q2
$336K Sell
1,824
-70
-4% -$12.5K 0.15% 56
2019
Q1
$360K Sell
1,894
-7
-0.4% -$1.34K 0.17% 49
2018
Q4
$370K Buy
1,901
+242
+15% +$47.2K 0.19% 48
2018
Q3
$344K Sell
1,659
-15
-0.9% -$2.96K 0.16% 56
2018
Q2
$309K Hold
1,674
0.15% 56
2018
Q1
$285K Hold
1,674
0.15% 56
2017
Q4
$291K Hold
1,674
0.15% 48
2017
Q3
$312K Hold
1,674
0.17% 43
2017
Q2
$288K Buy
1,674
+75
+5% +$12.2K 0.17% 43
2017
Q1
$262K Hold
1,599
0.15% 45
2016
Q4
$234K Buy
+1,599
New +$241K 0.14% 47

Other funds holding AMGN

Cheviot Value Management's AMGN Position: Q2 2026 in Review

Cheviot Value Management increased its Amgen (AMGN) stake by 3.5% in Q2 2026, buying an estimated $44.5K and bringing the position to 3,892 shares worth $1.41M. The position accounts for 0.14% of the portfolio, ranked #57.

Cheviot Value Management first reported a position in AMGN in Q4 2016 and has held it in 39 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Cheviot Value Management held 3,892 shares of Amgen worth $1.41M as of Q2 2026.
  • Cheviot Value Management bought 130 Amgen shares in Q2 2026, an estimated $44.5K.
  • Amgen made up 0.14% of Cheviot Value Management's portfolio in Q2 2026, its #57 holding.
  • Cheviot Value Management first reported a position in Amgen in Q4 2016 and has held it in 39 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Cheviot Value Management's 13F filing for Q2 2026, filed 6 Aug 2026.